Image

Global Nail Psoriasis Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Nail Psoriasis Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Nail Psoriasis Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3,461.12 USD Million
Diagram Market Size (Forecast Year) USD 4,736.78 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Nail Psoriasis Treatment Market, By Treatment (Corticosteroids, Retinoid, Phototherapy, Biologics, Systemic Medications, Others), Diagnosis (Physical Examination, Biopsy, Others), Dosage (Tablet, Injection, Ointment, Others), Route of Administration (Oral, Injectable, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Nail Psoriasis Treatment Market

Nail Psoriasis Treatment Market Analysis and Size

According to a systematic review and meta-analysis published in the Journal of the American Academy of Dermatology, the overall prevalence of nail psoriasis in individuals with psoriasis was estimated to be 37.4%. However, the prevalence varied widely depending on the population studied, with a range of 7% to 81%.

Data Bridge Market Research analyses that the nail psoriasis treatment market which was USD 3,461.12 million in 2022, would rocket up to USD 4,736.78 million by 2030, and is expected to undergo a CAGR of 4.0% during the forecast period. This indicates the market value. “Corticosteroids” dominates the treatment segment of the nail psoriasis treatment market owing to the growing demand for better treatment methods. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nail Psoriasis Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, and Pricing in USD

Segments Covered

Treatment (Corticosteroids, Retinoid, Phototherapy, Biologics, Systemic Medications, Others), Diagnosis (Physical Examination, Biopsy, Others), Dosage (Tablet, Injection, Ointment, Others), Route of Administration (Oral, Injectable, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Sun Pharmaceutical Industries Ltd. (India), Merck Sharp & Dohme Corp. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Cipla Inc. (India), AstraZeneca (U.K.), Johnson & Johnson Private Limited (India), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), LEO Pharma A/S (Denmark), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), Sumitomo Dainippon Pharma Co., Ltd. (Japan), Amgen Inc. (U.S.), Zydus Cadila (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Aurobindo Pharma (India), Lupin (India), and AbbVie Inc. (U.S.)

Market Opportunities

  • Development of new therapies
  • Collaboration and partnerships between market players

Market Definition

Psoriasis affecting the nail matrix or nail bed causes nail psoriasis, also known as psoriatic nail dystrophy, which causes specific and non-specific clinical changes in the nail. Psoriatic nail disease is frequently connected with chronic severe cutaneous psoriasis and may be a risk factor for the development of psoriatic arthritis. Nail psoriasis can affect people of various ethnicities, ages, and genders. The appearance of your toenails and fingernails is affected by nail psoriasis. It's possible that they'll thicken, acquire pinprick holes, and alter colour or shape. They can also be tender and painful.

Global Nail Psoriasis Treatment Market Dynamics

Drivers

  • Increasing Awareness and Diagnosis

With increasing awareness of nail psoriasis and improved diagnostic techniques, there is a growing number of individuals seeking treatment for this condition.

  • Increasing Incidence of Psoriatic Arthritis

Psoriatic arthritis is a common complication of psoriasis, and nail involvement is a common feature of psoriatic arthritis. As a result, there is a growing demand for effective treatments for nail psoriasis in individuals with psoriatic arthritis.

Opportunities

  • Development of New Therapies

While there are currently no drugs specifically approved for the treatment of nail psoriasis, there is a significant opportunity for the development of new therapies that target this specific manifestation of psoriasis. This could include the development of new topical or systemic therapies or the repurposing of existing drugs for the treatment of nail psoriasis.

  • Collaboration and Partnerships Between Market Players

There is a growing trend towards collaboration and partnerships between pharmaceutical companies, academic institutions, and other stakeholders in the healthcare industry. This approach could be particularly relevant for the development of new therapies for nail psoriasis, as it could bring together expertise from different fields to accelerate the development of effective treatments.

Restraints/Challenges

  • Limited Awareness and Under-Diagnosis

Nail psoriasis is often underdiagnosed and can be mistaken for other nail conditions such as fungal infection. Limited awareness among healthcare providers and patients can lead to delays in diagnosis and treatment.

  • Lack of specific treatments

There are currently no drugs specifically approved for the treatment of nail psoriasis. While there are several treatment options available for psoriasis in general, these may not be effective for all individuals with nail psoriasis.

This nail psoriasis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nail psoriasis treatment market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In June 2021, Almirall received FDA approval for Klisyri, a topical solution containing tirbanibulin, for the treatment of actinic keratosis, which can also affect the nails
  • In September 2020, Leo Pharma received FDA approval for Enstilar, a topical foam containing calcipotriene and betamethasone dipropionate, for the treatment of plaque psoriasis, including nail psoriasis
  • In May 2019, AbbVie received FDA approval for Skyrizi, a biologic therapy for the treatment of moderate to severe psoriasis, including nail psoriasis.

Global Nail Psoriasis Treatment Market Scope

The nail psoriasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Corticosteroids
  • Retinoid
  • Phototherapy
  • Biologics
  • TNF-alpha inhibitors
  • Adalimumab
  • Certolizumab Pegol
  • Etanercept
  • Etanercept-szzs
  • Infliximab
  • Interleukin-17 inhibitors
  • Brodalumab
  • Ixekizumab
  • Secukinumab
  • Interleukin- 23 inhibitors
  • Guselkumab
  • TIldrakizumab
  • Interleukin 12 and 23 inhibitor
  • Systemic Medications
  • Acitretin
  • Apremilast
  • Cyclosporine
  • Methotrexate
  • Others

 Diagnosis

  • Biopsy
  • Physical Examination
  • Others

Dosage

  • Tablet
  • Injection
  • Ointment
  • Others

Route of Administration

  • Oral
  • Topical
  • Injectable
  • Others

End-Users

  • Clinic
  • Hospital
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Nail Psoriasis Treatment Market Regional Analysis/Insights

The global nail psoriasis treatment market is analysed and market size insights and trends are provided by country, treatment, diagnosis, dosage, route of administration, end-users, and distribution channel as referenced above.

The countries covered in the nail psoriasis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and rest of South America as part of South America.

North America is expected to dominate the nail psoriasis treatment market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having psoriasis.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for skin care, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The nail psoriasis treatment market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the nail psoriasis treatment market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the nail psoriasis treatment market.

Competitive Landscape and Nail Psoriasis Treatment Market Share Analysis

The nail psoriasis treatment market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the nail psoriasis treatment market are:

  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck Sharp & Dohme Corp. (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Cipla Inc. (India)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (India)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • LEO Pharma A/S (Denmark)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • Eli Lilly and Company (U.S.)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Amgen Inc. (U.S.)
  • Zydus Cadila (India)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • AbbVie Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Nail Psoriasis Treatment Market will be worth USD 4,736.78 million by 2030.
The Nail Psoriasis Treatment Market Growth Rate is 4.0% during the forecast period.
The Increasing Incidence of Psoriatic Arthritis and Increasing Awareness and Diagnosis are the Growth drivers of the Nail Psoriasis Treatment Market.
The treatment, diagnosis, dosage, route of administration, end-users, and distribution channel are the factors on which the Nail Psoriasis Treatment Market research is based.
The Almirall received FDA approval for Klisyri, a topical solution containing tirbanibulin, for the treatment of actinic keratosis, which can also affect the nails and Leo Pharma received FDA approval for Enstilar, a topical foam containing calcipotriene and betamethasone dipropionate, for the treatment of plaque psoriasis, including nail psoriasis are the latest developments in the Nail Psoriasis Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials